Tian-en Li
12 Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma.
Journal: Cellular & molecular immunology
Published: June 26, 2021
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities.
Journal: Theranostics
Published: June 01, 2021
PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.
Journal: Frontiers in immunology
Published: July 31, 2020
IFN-α facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma.
Journal: American journal of translational research
Published: December 05, 2019
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
Journal: British journal of cancer
Published: October 09, 2019
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Journal: Journal of surgical oncology
Published: July 10, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026